List view / Grid view

Sapreme Technologies



Coupling large molecules with targeting and delivery mechanisms to augment intracellular delivery

21 February 2022 | By ,

Most intracellular drug targets remain intractable due to cellular membranes effectively denying large foreign molecules entry into the cytoplasm. Over recent decades, several technologies that enable biologics to enter cells have emerged, but successes remain limited to date. Here, Sapreme Technologies’ Miriam Bujny, Chief Development Officer, and Guy Hermans, Chief…